初创公司尽调
最新私募市场研究

初创公司尽调,
由 AI 撰写。

每份报告对一家非上市初创公司进行端到端研究,按投资委员会备忘录的格式撰写:封面快照、执行摘要、市场规模、竞争对手、财务、产品、客户、风险与估值。每条结论都链接到公开来源。

最新报告

按生成时间排序,最新报告在前。高分榜在独立页面查看。

查看全部
Mobility finance and autonomous-fleet operations Late-stage private; Series C

Moove

Moove has reported substantial operating scale and a $2.1 billion Series C valuation, but unverified earnings, capital needs, and partner exposure make investment approval premature.

继续研究 未知 风险: 高
估值
$2.1B
年经常性收入
$420M
public safety software private

Mark43

Mark43 has meaningful public-sector reach and a broad mission-critical platform, but undisclosed economics, ambiguous customer metrics, and unpriced acquisition terms leave valuation and returns ununderwritable.

继续研究 未知 风险: 高
Healthcare / Biotechnology — Antibody-Drug Conjugates Public, clinical-stage

LigaChem Biosciences

LigaChem’s partnered ADC platform and selective in-house clinical progress offer meaningful optionality, but losses, uncertain cash runway, contingent deal economics, and the absence of a defensible current valuation support research-more rather than a high-conviction entry.

继续研究 未知 风险: 高
Healthcare / Biotech Clinical-stage private

LifeMine Therapeutics

LifeMine's 2026 financing and ongoing Phase 1 program merit tracking, but undisclosed transaction terms, liquidity, and independent clinical outcomes leave valuation and entry price unassessable.

观察 未知 风险: 高
fintech / BNPL / digital credit / digital banking late-stage private

Kredivo

Kredivo combines established digital-credit scale and banking optionality, but missing parent economics, credit cohorts, and a current entry price support further diligence rather than an investment commitment.

继续研究 未知 风险: 高
Procurement software / spend management Private; Hg acquisition reported in 2024

Ivalua

Ivalua has a credible, broad enterprise source-to-pay platform, but undisclosed current economics, transaction terms, and governance prevent a high-conviction valuation call; further diligence is warranted.

继续研究 未知 风险: 高
Decentralized identity / biometrics / blockchain Private company; token-network project

Humanity Protocol

Humanity Protocol has product activity and identity-market optionality, but the 2026 key compromise, unproven commercial conversion, and absent current financial disclosure keep the recommendation at research-more.

继续研究 未知 风险: 高
insurance telematics / mobility AI growth-stage private company

Cambridge Mobile Telematics

CMT has a scaled telematics platform and strategic validation, but opaque economics and an unverified cyber allegation support further diligence rather than an entry decision.

继续研究 未知 风险: 高
AI infrastructure / AI-factory development Private; Seed and Series A disclosed

Volta

Volta's financing-led AI-factory model is differentiated, but public evidence supports research-more discipline rather than underwriting its reported $2.4 billion valuation.

继续研究 偏高 风险: 高
估值
$2.4B
battery manufacturing / energy storage Private; current financing stage undisclosed

Our Next Energy (ONE)

ONE's LFP platform and customer activity support continued diligence, but delivery conversion, current unit economics, financing terms, and liquidity remain unverified.

继续研究 未知 风险: 高
fintech Series C, late-stage private

Moss

Moss has reported late-stage scale and an integrated finance workflow, but conflicting financing disclosures and unverified unit economics, retention, and capital terms leave the €1.0bn mark too difficult to underwrite for a buy.

观察 偏高 风险: 高
Consumer / food & beverage / specialty coffee Late-stage private company

Manner Coffee

Reported scale and a compact, value-oriented format merit continued diligence, but financial opacity, execution risks, and the absence of a verified current valuation preclude an investment call.

继续研究 未知 风险: 高

已显示 12 / 1,437 报告.

查看全部 1,437 份报告 →